Related Experiment Video
Updated: May 6, 2026

Asthma Detection Research Based on Voice Signal Processing and Machine Learning
Published on: July 22, 2025
Non-adherence in difficult asthma and advances in detection
John T Lindsay1, Liam G Heaney
1Centre for Infection and Immunity, Health Sciences Building, Queens University Belfast, Lisburn Road, Belfast, UK.
Non-adherence to anti-inflammatory therapies is common in difficult-to-treat asthma, worsening outcomes. This review explores adherence measurement, detection, and strategies to improve treatment compliance in these patients.
Area of Science:
- Pulmonology
- Asthma Research
- Patient Adherence Studies
Background:
- Non-adherence to anti-inflammatory therapies is prevalent in difficult-to-treat asthma.
- Poor adherence is linked to worse asthma control, more exacerbations, hospitalizations, and mortality.
Purpose of the Study:
- To review the literature on non-adherence prevalence and risks in difficult asthma.
- To report on current adherence measurement and detection methods.
- To explore strategies for addressing non-adherence.
Main Methods:
- Literature review of current research on difficult asthma treatment adherence.
- Analysis of methods for measuring and detecting non-adherence.
- Exploration of interventions to improve adherence.
Main Results:
- Non-adherence is a significant issue in difficult-to-treat asthma populations.
- Existing methods for measuring and detecting non-adherence vary in effectiveness.
- Various strategies can be employed to improve patient adherence.
Conclusions:
- Addressing non-adherence is crucial for managing difficult-to-treat asthma.
- Improved adherence monitoring and targeted interventions are needed.
- Further research into effective adherence strategies is warranted.
Related Concept Videos
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-IV: Nursing Management
First, in...
Asthma III: Clinical Manifestations
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-III: Symptoms and Complications
Classification of Asthma
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...

